• Vivet Therapeutics

    Vivet Therapeutics
    raises €37.5 million in Series A financing round to advance novel gene therapies for treating inherited metabolic diseases

    Read More
  • Transforming Lives

    Transforming Lives
    Novel gene therapies for rare, inherited metabolic diseases

    Read More
  • Wilson’s Disease

    Wilson’s Disease
    Benefits of AAV gene therapy as a novel approach to manage Wilson’s disease

    Read More

Welcome to Vivet Therapeutics

Vivet Therapeutics is dedicated to developing innovative gene therapy treatments for orphan diseases.

Vivet Therapeutics is focused on optimizing gene therapy through collaborating with the Fundacion para la Investigacion Medica Aplicada (FIMA) at the Centro de Investigación Medica Aplicada (CIMA, Universidad de Navarra)  to develop new AAV vectors specifically targeting the liver and generating new technologies to optimize gene delivery and long term expression.

Latest News